These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33078111)

  • 1. Intravitreal dexamethasone implant in naïve and previously treated patients with diabetic macular edema: a retrospective study.
    Medina-Baena M; Cejudo-Corbalán O; García-Pulido JI; Huertos-Carrillo MJ; Girela-López E
    Int J Ophthalmol; 2020; 13(10):1597-1605. PubMed ID: 33078111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex
    Udaondo P; Hervas-Ontiveros A; Rosemblatt A; Garcia-Delpech S
    Clin Ophthalmol; 2021; 15():4153-4162. PubMed ID: 34703201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study.
    Menezo M; Roca M; Menezo V; Pascual I
    Curr Med Res Opin; 2019 Dec; 35(12):2111-2116. PubMed ID: 31378087
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early efficacy of dexamethasone implant (OZURDEX
    Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Dexamethasone Intravitreal Implant in Naïve and Previously Treated Patients with Diabetic Macular Edema.
    Medina-Baena M; Cejudo-Corbalán O; Labella-Quesada F; Girela-López E
    Int J Environ Res Public Health; 2023 Apr; 20(8):. PubMed ID: 37107744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes.
    Neves P; Ornelas M; Matias I; Rodrigues J; Santos M; Dutra-Medeiros M; Martins D
    Int J Ophthalmol; 2021; 14(10):1571-1580. PubMed ID: 34667735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 11. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study.
    Scorcia V; Giannaccare G; Gatti V; Vaccaro S; Piccoli G; Villì A; Toro MD; Yu AC; Iovino C; Simonelli F; Carnevali A
    Ophthalmol Ther; 2021 Dec; 10(4):1015-1024. PubMed ID: 34482532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter Ozurdex® assessment for diabetic macular edema: MOZART study].
    Guigou S; Hajjar C; Parrat E; Merite PY; Pommier S; Matonti F; Prost-Magnin O; Meyer F
    J Fr Ophtalmol; 2014 Jun; 37(6):480-5. PubMed ID: 24813119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience.
    Hsia NY; Lin CJ; Chen HS; Chang CH; Bair H; Lai CT; Lin JM; Chen WL; Tien PT; Wu WC; Tsai YY
    Front Med (Lausanne); 2021; 8():649979. PubMed ID: 33996856
    [No Abstract]   [Full Text] [Related]  

  • 16. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, Observational, Multicenter, Real-World Study of the Efficacy, Safety, and Pattern of Use of the Dexamethasone Intravitreal Implant in Diabetic Macular Edema in France: Short-Term Outcomes of LOUVRE 3.
    Kodjikian L; Delcourt C; Creuzot-Garcher C; Massin P; Conrath J; Velard MÈ; Lassalle T; Pinchinat S; Dupont-Benjamin L
    Ophthalmol Ther; 2023 Jun; 12(3):1671-1692. PubMed ID: 36967448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
    Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
    Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
    Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
    Boyer DS; Yoon YH; Belfort R; Bandello F; Maturi RK; Augustin AJ; Li XY; Cui H; Hashad Y; Whitcup SM;
    Ophthalmology; 2014 Oct; 121(10):1904-14. PubMed ID: 24907062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.